Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Ludwig Englmeier has worked on the following 5 EPO patent applications which have been published in the last five years:

EP11182256

Compressed oral dosage form for asenapine maleate

IPC classification:
A61K 9/00, A61K 9/20, A61K 31/407
Applicant:
Hexal AG
Agent:
Ludwig Englmeier, Sandoz International GmbH
Status:
APPLICATION REFUSED
EP13176400

Process for the preparation of form III of Vilazodone hydrochloride

IPC classification:
C07D 405/12
Applicant:
Sandoz AG
Agent:
Ludwig Englmeier, Sandoz International GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13198012

Crystalline form of mastinib mesylate

IPC classification:
A61K 31/4439, C07D 417/04
Applicant:
Sandoz AG
Agent:
Ludwig Englmeier, Sandoz International GmbH
Status:
EXAMINATION IN PROGRESS
EP14179182

Dosage form comprising a pressure sensitive solid form of an active pharmaceutical ingredient

IPC classification:
A61K 9/20, A61K 31/52
Applicant:
Sandoz AG
Agent:
Ludwig Englmeier, Sandoz International GmbH
Status:
APPLICATION REFUSED
EP15151854

AMORPHOUS AND CRYSTALLINE FORMS OF IDELALISIB AND PROCESS FOR FORMING THE SAME

IPC classification:
A61K 31/52, C07D 473/34
Applicant:
Sandoz AG
Agent:
Ludwig Englmeier, Sandoz International GmbH
Status:
APPLICATION REFUSED

Please Sign in to use this feature